Psoriasis
Treatment Market Growth Research Report: Information by Drug Class [Tumour
Necrosis Factor Inhibitors (Adalimumab, Infliximab and Etanercept),
InterleU.K.in-Inhibitors (Ustekinumab, SecU.K.inumab, Ixekizumab and
Brodalumab), Vitamin D Analogues (Calcitriol, Calcipotriol and Tacalcitol)],
Treatment Type {Topicals [Over-the-counter (OTC) Topicals, Topical Non-Steroids
and Topical Steroids], Systemic (Retinoid, Cyclosporine and Methotrexate),
Biologics [Tumour Necrosis Factor Alpha (TNF-α) Inhibitors, InterleU.K.in 12
and 23 (IL-12/23) Inhibitors, InterleU.K.in 17 (IL-17) Inhibitor, T cell
Inhibitor]} and Region (Americas, Europe, Asia-Pacific and Middle East &
Africa) - Forecast till 2025
Market Analysis
The Psoriasis
Treatment Market Growth is predicted to touch
USD 13.1 billion at a 7.3% CAGR between 2019-2025, states the latest Market
Research Future (MRFR) report. Psoriasis, simply put, is an autoimmune
condition that causes rapid development of cells on the skin. The overgrowth
can result in scaly, thick plaques that may itch and cause discomfort. Scales
generally develop on joints, especially the knees and elbows, but it may appear
in any part of the body including the face, scalp, neck, feet, and hands.
Various factors are propelling
the global Psoriasis Treatment Market Growth growth. Such factors, according to
the latest Market Research Future report, include vulnerability towards
psoriatic arthritis, favorable reimbursement policies, growing awareness about
psoriasis, increasing availability of biosimilars and biologics, aging
population and changing lifestyle. Additional factors propelling the growth of
the Psoriasis Treatment Market Growth include rising prevalence of autoimmune diseases,
increasing incidence of psoriasis, increasing R&D activities for psoriasis
treatment, and technological advancements.
On the contrary, lack of
knowledge regarding the exact cause of psoriasis and its etiology, the high
price of medications with their low efficacy and efficiency, side effects
associated with symptomatic treatments, and lack of permanent and effective
treatment are factors that may hamper the Psoriasis Treatment Market Growth
growth during the forecast period.
Market Segmentation
The Market Research Future
report offers a complete segmental analysis of the Psoriasis Treatment Market
Growth based on treatment type and drug class.
By drug class, the Psoriasis
Treatment Market Growth is segmented into vitamin D analogues,
InterleU.K.in-inhibitors, and tumor necrosis factor inhibitors. The tumor
necrosis factor inhibitors segment is again segmented into etanercept,
infliximab, and adalimumab. The InterleU.K.in-inhibitors segment is again
segmented into brodalumab, ixekizumab, SecU.K.inumab, and ustekinumab. The
vitamin D analogues segment is again segmented into tacalcitol, calcipotriol,
and calcitriol.
By treatment, the Psoriasis
Treatment Market Growth is segmented into biologics, systematic, and topicals.
The topicals segment is again segmented into topical steroids, topical
non-steroids, and over the counter topicals. The systematic segment is again
segmented into methotrexate, cyclosporine, and retinoid. The biologics segment is
again segmented into T cell inhibitor, InterleU.K.in 17 (IL-17) inhibitor,
InterleU.K.in 12 and 23 (IL-12/23) inhibitors, and tumor necrosis factor-alpha
(TNF-a) inhibitors.
Browse Complete Report :https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769
Regional Analysis
By region, the Psoriasis
Treatment Market Growth report covers the latest trends and growth
opportunities across the Americas, Europe, the Asia Pacific, the Middle East
and Africa, and Latin America. Of these, North America will spearhead the
market during the forecast period. Various factors are propelling the growth of
the Psoriasis Treatment Market Growth in the region, such as the growing
awareness about psoriasis treatment, rising prevalence of psoriasis, presence
of key manufacturers, and increasing health infrastructure.
The Psoriasis Treatment Market
Growth in Europe will have the second-largest share during the forecast period.
Various factors are propelling the growth of the Psoriasis Treatment Market
Growth in the region such as growing awareness about psoriasis, the launch of
biosimilars (amzevita, elerzi), and increasing prevalence of psoriasis.
The Psoriasis Treatment Market
Growth in the APAC region will grow at the fastest pace during the forecast
period. Various factors are propelling the growth of the Psoriasis Treatment
Market Growth in the region such as growing geriatric population, large patient
pool, improving medical facilities and healthcare infrastructure, increasing
participation of key market players, increasing investments to develop new
therapeutics to treat psoriasis, and increasing awareness.
The Psoriasis Treatment Market
Growth in the MEA will have a small share during the forecast period for the
low economic development in Africa.
The Psoriasis Treatment Market
Growth in Latin America will have a favorable growth during the forecast period
owing to the focus of manufacturers to create novel therapeutics and rise in
the psoriasis patient pool.
Key Players
Notable players profiled in the Psoriasis
Treatment Market Growth report include Eli Lilly and Company (US), Amgen (US),
AbbVie (US), Merck and Co. Inc (US), Pfizer Inc (US), Johnson & Johnson
(US), Celgene Corporation (US), AstraZeneca (UK), UCB (Belgium), and Novartis
International AG (Switzerland).
Industry News
Dec 2019: Daavlin, a renowned
US-based phototherapy units’ manufacturer that utilizes therapeutic UV light to
effectively and safely treat patients with eczema, vitiligo, and psoriasis have
joined hands with HealthLens to give patients better access to receive a
dermatology consultation as well as treatment right from their home. The
patient just needs to book a consultation online, followed by uploading some
pictures of the skin condition and brief health history, after which the
information will get electronically encrypted and sent securely to the
physician who will respond within 1-2 days.
No comments:
Post a Comment